Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Dr. Mitchell Gaynor Unveils The Next Step In Evolutionary Health Optimization
  • USA - English


News provided by

Gene Response, Inc.

Nov 19, 2014, 04:00 ET

Share this article

Share toX

Share this article

Share toX

Mitchell L. Gaynor, M.D.
Mitchell L. Gaynor, M.D.

NEW YORK, NY (PRWEB) November 19, 2014 -- “It is never too late to bring back the balance,” says Dr. Gaynor.

“It is never too late to bring back the balance,” says Dr. Gaynor.

Post this

Dr. Mitchell Gaynor's revolutionary Gene Therapy Plan, employs a variety of techniques to optimize each individual's gene expression for peak health and performance. These tools include targeted nutrients, stress reduction techniques, diet, exercise, and lifestyle recommendations. In both his latest book, and his new blog, Dr. Gaynor documents the science which shows how these programs reverse degenerative changes that occur through toxin exposure, stress, chronic inflammation, and obesity. Dr. Gaynor's Gene Therapy Plan empowers individuals with the opportunity to take control of their genetic code and re-write their genetic destiny.

"Toxicogenomics" is the term for toxins adversely affecting gene expression. However, “Our bodies are not static and destiny is not fixed,” Dr. Gaynor emphasizes, and "Nutritional Genomics" is one of the primary focus-areas in Dr. Gaynor's work.

This emerging area of genetic science is known as "Epignetics," which is the study of factors other than one’s inherited DNA that influence gene expression. With understanding in this field growing rapidly, health professionals are embracing Epigenetics as a key aspect to treatment and wellness. Dr. Gaynor's Gene Therapy Plan is at the forefront of this revolution. It represents the next step in the evolution of health optimization.

Dr. Gaynor's Gene Therapy programs (outlined in his book and blog), are ideal for anyone looking to maximize longevity and lifestyle wellness. Through a variety of scientifically-supported techniques, your gene expression can be literally transformed, thereby assisting better health for your children and future generations. By following the techniques in Dr. Gaynor's Gene Therapy programs you will be able to fully-optimize your genetic makeup.

In conjunction with his revolutionary genetic expression programs, Dr. Gaynor's Blog and Newsletter can be found at: http://www.genechanger.com. Daily content updates will reflect Dr. Gaynor's cutting-edge approach to wellness, and will expand-upon his insights on Nutritional Genomics, Diet, Exercise, Stress-Reduction, Lifestyle, and Oncology, as well as real-time medical developments in these areas.

Dr. Gaynor's fifth book, published by Viking Penguin books, is scheduled for release in April 2015, and is aptly-titled, "The Gene Therapy Plan- Taking Control of your Genetic Destiny Through Diet and Lifestyle", is now available for pre-order. The foreword is written by well-known cardiothoracic surgeon and television personality, Dr. Mehmet Oz.

About Us: Dr. Mitchell L. Gaynor is a distinguished physician, author and lecturer based in New York City. He has been a renowned pioneer in the field of integrative oncology for more than 30 years. Dr. Gaynor has also been a leader in the treatment of chronic diseases by using scientifically-grounded therapies to augment traditional care. He has been consecutively listed in "The Best Doctors in New York" every year since 1997. He is board certified in medical oncology, hematology and internal medicine, and a member of the American Society of Clinical Oncology, the American College of Physicians, and the New York Academy of Sciences.

Dr. Gaynor is Founder and President of Gaynor Integrative Oncology (http://www.drgaynor.com), and is Assistant Clinical Professor of Medicine at Weill-Cornell Medical College. He has held the position of Director of Medical Oncology at The Strang Cancer Prevention Center where he still serves as a consultant.

Dr. Gaynor has served on the Board of Advisors for Healthy Living Magazine, the Sass Medical Foundation, as well as the editorial board of Integrative Cancer Therapies. After receiving his medical degree from the University of Texas - Southwestern Medical School in Dallas, Texas, he was a clinical fellow in hematology-oncology at the New York Hospital-Cornell Medical Center and a post-doctorate fellow in molecular biology at Rockefeller University, New York City.

Dr. Gaynor has been featured in many national newspapers, including The New York Times, USA Today, Newsday, The New York Post, and New York Daily News. He has also been a source for articles in many national magazines including Newsweek, Publishers Weekly, Self, GQ, Healthy Living, New Texas Magazine and USA Weekend. He has appeared widely on television, including CBS Evening News with Dan Rather, ABC Good Morning America, Discovery Health-She, Fox News Channel, WNET-Channel 13 with Dr. Frank Field, Healthy Living with Jane Seymour, CBS-48 Hours and CNN Your Health.

Erica Vargas, Gene Response, Inc., http://genechanger.com/, +1 (212) 472-2828, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.